Gender differences in hemorheological parameters and in in vitro platelet aggregation in acetylsalicylic acid and clopidogrel treated vascular patients

Biorheology

Volumn 51, Issue 2, 2014, Pages 197-206

  Koltai, Katalin ^a   Papp, Judit ^a   Kenyeres, Peter ^a   Feher, Gergely ^a   Tibold, Antal ^a   Alexy, Tamas ^a,b   Marton, Zsolt ^a   Kesmarky, Gabor ^a   Toth, Kalman ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aspirin; Erythrocyte aggregation; Fibrinogen; Optical aggregometry; Thienopyridines; Viscosity

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; FIBRINOGEN; TICLOPIDINE;

ARTICLE; BLOOD RHEOLOGY; BLOOD VISCOSITY; ERYTHROCYTE AGGREGATION; FEMALE; HEMATOCRIT; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PLASMA VISCOSITY; SEX DIFFERENCE; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; AGED; ANALOGS AND DERIVATIVES; FLOW KINETICS; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

AGED; ASPIRIN; ERYTHROCYTE AGGREGATION; FEMALE; FIBRINOGEN; HEMATOCRIT; HUMANS; IN VITRO TECHNIQUES; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RHEOLOGY; TICLOPIDINE;

EID: 84925351739     PISSN: 0006355X     EISSN: 18785034     Source Type: Journal    
DOI: 10.3233/BIR-140661     Document Type: Article

References (30)

1. D.M. Becker, J. Segal, D. Vaidya, L.R. Yanek, J.E. Herrera-Galeano, P.F. Bray, T.F.Moy, L.C. Becker and N. Faraday, Sex differences in platelet reactivity and response to low-dose aspirin therapy, J. Am. Med. Assoc. 295 (2006), 1420-1427.
2. J.S. Berger, D.L. Bhatt, C.P. Cannon, Z. Chen, L. Jiang, J.B. Jones, S.R. Mehta, M.S. Sabatine, S.R. Steinhubl, E.J. Topol and P.B. Berger, The relative efficacy and safety of clopidogrel in women and men a sex-specific collaborative meta-analysis, J. Am. Coll. Cardiol. 54 (2009), 1935-1945.
3. J.S. Berger, L. Elliott, D. Gallup, M. Roe, C.B. Granger, P.W. Armstrong, R.J. Simes, H.D. White, F. Van de Werf, E.J. Topol, J.S. Hochman, L.K. Newby, R.A. Harrington, R.M. Califf, R.C. Becker and P.S. Douglas, Sex differences in mortality following acute coronary syndromes, JAMA 302 (2009), 874-882.
4. J.S. Berger, M.J. Krantz, J.M. Kittelson and W.R. Hiatt, Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials, J. Am. Med. Assoc. 301 (2009), 1909-1919.
5. P. Bobbert, C. Stellbaum, D. Steffens, C. Schütte, T. Bobbert, H.P. Schultheiss and U. Rauch, Postmenopausal women have an increased maximal platelet reactivity compared to men despite dual antiplatelet therapy, Blood Coagul. Fibrinolysis 23 (2012), 723-728.
6. L. Bogar, I. Juricskay, G. Kesmarky, G. Feher, P. Kenyeres and K. Toth, Gender differences in hemorheological parameters of coronary artery disease patients, Clin. Hemorheol. Microcirc. 35 (2006), 99-103.
7. G.V. Born and M.J. Cross, The aggregation of blood platelets, J. Physiol. 168 (1963), 178-195.
8. D. Capodanno and D.J. Angiolillo, Impact of race and gender on antithrombotic therapy, Thromb. Haemost. 104 (2010), 471-484.
9. Y. Chen, L. Jiang, M. Smith, H. Pan, R. Collins, R. Peto and Z. Chen, Sex differences in hospital mortality following acute myocardial infarction in China: findings from a study of 45852 patients in the COMMIT/CCS-2 study, Heart Asia 3 (2011), 104-110.
10. Z.M. Chen, L.X. Jiang, Y.P. Chen, J.X. Xie, H.C. Pan, R. Peto, R. Collins and L.S. Liu, COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial, Lancet 366 (2005), 1607-1621.
11. G. Feher, K. Koltai, G. Kesmarky and K. Toth, Hemorheological background of acetylsalicylic acid resistance, Clin. Hemorheol. Microcirc. 38 (2008), 143-152.
12. G. Feher, K. Koltai, E. Papp, B. Alkonyi, A. Solyom, P. Kenyeres, G. Kesmarky, L. Czopf and K. Toth, Aspirin resistance: possible roles of cardiovascular risk factors, previous disease history, concomitant medications and haemorrheological variables, Drugs Aging 23 (2006), 559-567.
13. F.G. Fowkes, J.P. Pell, P.T. Donnan, E. Housley, G.D. Lowe, R.A. Riemersma and R.J. Prescott, Sex differences in susceptibility to etiologic factors for peripheral atherosclerosis. Importance of plasma fibrinogen and blood viscosity, Arterioscler. Thromb. 14 (1994), 862-868.
14. J.C. Galduróz, H.K. Antunes and R.F. Santos, Gender- and age-related variations in blood viscosity in normal volunteers: a study of the effects of extract of Allium sativum and Ginkgo biloba, Phytomedicine 14 (2007), 447-451.
15. M. Gudmundsson and A. Bjelle, Plasma, serum and whole-blood viscosity variations with age, sex, and smoking habits, Angiology 44 (1993), 384-391.
16. P.C. Ho, E.J. Triggs, D.W. Bourne and V.J. Heazlewood, The effects of age and sex on the disposition of acetylsalicylic acid and its metabolites, Br. J. Clin. Pharmacol. 19 (1985), 675-684.
17. A.R. Hobson, Z. Qureshi, P. Banks and N. Curzen, Gender and responses to aspirin and clopidogrel: insights using short thrombelastography, Cardiovasc. Ther. 27 (2009), 246-252.
18. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group, that Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2, Lancet 2 (1988), 349-360.
19. M. Izadnegahdar, J. Singer, M.K. Lee, M. Gao, C.R. Thompson, J. Kopec and K.H. Humphries, Do younger women fare worse? Sex differences in acute myocardial infarction hospitalization and early mortality rates over ten years, J. Womens Health (Larchmt) 23 (2014), 10-17.
20. N. Jochmann, K. Stangl, E. Garbe, G. Baumann and V. Stangl, Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases, Eur. Heart J. 26 (2005), 1585-1595.
21. G. Kesmarky, K. Toth, L. Habon, G. Vajda and I. Juricskay, Hemorheological parameters in coronary artery disease, Clin. Hemorheol. Microcirc. 18 (1998), 245-251.
22. H.J. Klose, E. Volger, H. Brechtelsbauer, L. Heinrich and H. Schmied-Schonbein, Microrheology and light transmission in blood, Pflugers Arch. 333 (1972), 126-139.
23. N. Nemeth, F. Kiss, I. Furka and I. Miko, Gender differences of blood rheological parameters in laboratory animals, Clin. Hemorheol. Microcirc. 45 (2010), 263-272.
24. M. Otahbachi, J. Simoni, G. Simoni, J.F. Moeller, C. Cevik, G.E. Meyerrose and C. Roongsritong, Gender differences in platelet aggregation in healthy individuals, J. Thromb. Thrombolysis 30 (2010), 184-191.
25. B. Pehlivanoglu, N. Dikmenoglu and D.Z. Balkanci, Effect of stress on erythrocyte deformability, influence of gender and menstrual cycle, Clin. Hemorheol. Microcirc. 37 (2007), 301-308.
26. M. Spranger, B.S. Aspey and M.J. Harrison, Sex difference in antithrombotic effect of aspirin, Stroke 20 (1989), 34-37.
27. S.R. Steinhubl, P.B. Berger, J.T. Mann 3rd, E.T. Fry, A. DeLago, C. Wilmer and E.J. Topol, CREDO investigators, clopidogrel for the reduction of events during observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial, J. Am. Med. Assoc. 288 (2002), 2411-2420.
28. T. Yerman, W.Q. Gan and D.D. Sin, The influence of gender on the effects of aspirin in preventing myocardial infarction, BMC Med. 5 (2007), 29.
29. S. Yusuf, F. Zhao, S.R. Mehta, S. Chrolavicius, G. Tognoni and K.K. Fox, Clopidogrel in unstable angina to prevent recurrent events trial investigators, effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation, N. Engl. J. Med. 345 (2001), 494-502.
30. D. Zeltser, O. Rogowski, S. Berliner, T.Mardi, D. Justo, J. Serov, M. Rozenblat, D. Avitzour and I. Shapira, Sex differences in the expression of haemorheological determinants in individuals with atherothrombotic risk factors and in apparently healthy people, Heart 90 (2004), 277-281.